• Mashup Score: 3

    Prostate cancer’s resistance to treatment can be reversed in some patients by stopping hijacked white blood cells from being ‘pulled into’ tumours, according to new research published in Nature.

    Tweet Tweets with this article
    • 💬🚨"This research proves for the first time that targeting #Myeloid cells can shrink tumours. This suggests we have an entirely new way to treat #ProstateCancer on the horizon.'' - Prof Johann De Bono, Professor in Experimental #CancerMedicine https://t.co/aFlNlrrVi3 https://t.co/05P6HUkaYR

  • Mashup Score: 2

    Anna Azvolinsky, PhD, is a freelance medical and science journalist based in New York City. Clonal hematopoiesis (CH) is relatively common, with up to 15% of adults age 60 and older estimated to have one of two CH conditions: CH of indeterminate potential (CHIP) and clonal cytopenia of undetermined significance (CCUS). The rate of diagnosis of these two conditions is steadily increasing. CH is associated with an increased risk of developing myeloid blood cancers but, for most patients, this risk is

    Tweet Tweets with this article
    • Using whole-exome sequencing data, researchers have developed a risk score that estimates a patient’s risk of progression from CHIP or CCUS to a #myeloid #malignancy and identifies patients at high risk for #clonalhematopoiesis https://t.co/KgLn3e5IKU

  • Mashup Score: 0

    Blood Podcast – Season 6, Episode 5 | Blood | American Society of Hematology Ventricular arrhythmias in sickle cell anemia, molecular heterogeneity of pediatric lymphoproliferative disorders, the role of the bone marrow microenvironment in myeloid disorders In this week’s episode, we’ll learn more about ventricular arrhythmias in sickle cell anemia, discuss the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders, and uncover…

    Tweet Tweets with this article
    • #VentricularArrhythmias in #SickleCell anemia, molecular heterogeneity of #Pediatric lymphoproliferative disorders, the role of the bone marrow microenvironment in #Myeloid disorders Check out this great podcast episode! 👉https://t.co/pHZluSpW9N @BloodJournal

  • Mashup Score: 0
    Wolters Kluwer Health - 11 month(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • Sara Meyer, PhD, @KimmelCancerCtr shares her thoughts on “understanding the molecular mechanisms that contribute to #myeloid leukemogenesis, with an emphasis on identifying new opportunities for therapeutic intervention." https://t.co/grzZxLkN1W https://t.co/ko30YgU8Ct

  • Mashup Score: 0
    Wolters Kluwer Health - 11 month(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • Sara Meyer, PhD, @KimmelCancerCtr shares her thoughts on “understanding the molecular mechanisms that contribute to #myeloid leukemogenesis, with an emphasis on identifying new opportunities for therapeutic intervention." https://t.co/grzZxLkN1W https://t.co/yTI8I7kHdY

  • Mashup Score: 0

    A cell therapy using myeloid cells bound to drug delivery microparticles reduces disease burden in a preclinical multiple sclerosis model

    Tweet Tweets with this article
    • A backpack full of #multiplesclerosis therapy https://t.co/6v4ZWQrYWy via @wyssinstitute A backpack-based #myeloid #celltherapy for multiple sclerosis | Proceedings of the National Academy of Sciences https://t.co/EHEf2w8UBj #MS #Autoimmune #EAE #Biomaterials #IL4 "We propose… https://t.co/s9b7VzIoQQ https://t.co/2wWuRLt7Yg